Skip to Content

Kaletra (80 mg + 20 mg) / ml oral solution

Licence status
Authorised: 20/03/2001
Active substances
Ritonavir, Lopinavir
Dosage Form
Oral solution
Licence number
EU/1/01/172/003
Licence holder
AbbVie Deutschland GmbH & Co. KG

Licence information

ATC code
J05AE Protease inhibitors, J05AE03 ritonavir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/03/2001